{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361418521197930240.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.ctrv.2017.08.007"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0305737217301305?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0305737217301305?httpAccept=text/plain"}}],"dc:title":[{"@value":"Pancreatic ductal adenocarcinoma: State-of-the-art 2017 and new therapeutic strategies"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381418521197930242","@type":"Researcher","foaf:name":[{"@value":"Marta Chiaravalli"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418521197930240","@type":"Researcher","foaf:name":[{"@value":"Michele Reni"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418521197930241","@type":"Researcher","foaf:name":[{"@value":"Eileen M. O'Reilly"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"03057372"}],"prism:publicationName":[{"@value":"Cancer Treatment Reviews"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2017-11","prism:volume":"60","prism:startingPage":"32","prism:endingPage":"43"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0305737217301305?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0305737217301305?httpAccept=text/plain"}],"createdAt":"2017-08-23","modifiedAt":"2020-10-16","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360005514541016704","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Targeting claudin‐4 enhances chemosensitivity of pancreatic ductal carcinomas"}]},{"@id":"https://cir.nii.ac.jp/crid/1360287219288077440","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"An Efficient Photodynamic Therapy Treatment for Human Pancreatic Adenocarcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360579814676355584","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Subtypes in pancreatic ductal adenocarcinoma based on niche factor dependency show distinct drug treatment responses"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861705585625216","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Gemcitabine Resistance in Pancreatic Ductal Carcinoma Cell Lines Stems from Reprogramming of Energy Metabolism"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.ctrv.2017.08.007"},{"@type":"CROSSREF","@value":"10.1002/cam4.2547_references_DOI_3nsVCbKZQikYA1ve6s8RIEg9C3q"},{"@type":"CROSSREF","@value":"10.3390/jcm9010192_references_DOI_3nsVCbKZQikYA1ve6s8RIEg9C3q"},{"@type":"CROSSREF","@value":"10.1186/s13046-022-02301-9_references_DOI_3nsVCbKZQikYA1ve6s8RIEg9C3q"},{"@type":"CROSSREF","@value":"10.3390/ijms23147824_references_DOI_3nsVCbKZQikYA1ve6s8RIEg9C3q"}]}